Theravance Biopharma Inc
TBPH | NASDAQ
$17.05
+$0.03 (+0.18%)
At close: Sep 21, 2026, 4:00 PM ET
$17.05
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 20.73M | 17.7M | 45.89M | 19.99M | 26.2M | 15.39M | 18.75M | 16.87M | 14.26M | 14.5M | 17.57M | 15.69M | 13.75M | 10.42M | 14.65M | 12.45M | 11.05M | 13.2M | 14.95M | 13.19M | 12.91M | 14.26M |
Cost of Revenue | n/a | n/a | 1.51M | 8.11M | 10.49M | 11.45M | 9.45M | 9.27M | 9.95M | 8.97M | 8.31M | 1.34M | 9.43M | 14.57M | 15.35M | 9.87M | 14.92M | 23.25M | 31.23M | 43.74M | 51.09M | 67.6M |
Gross Profit | 20.73M | 17.7M | 44.39M | 11.88M | 15.71M | 3.94M | 9.3M | 7.6M | 4.3M | 5.54M | 9.25M | 14.35M | 4.32M | -4.16M | -699K | 2.58M | -3.87M | -10.06M | -16.28M | -30.55M | -38.18M | -53.34M |
Operating Income | -8.28M | -5.85M | 17.57M | -6.46M | -2.73M | -14.43M | -9.2M | -10.84M | -15.71M | -11.21M | -6.24M | -8.76M | -16.12M | -24.91M | -17.43M | -14.2M | -23.1M | -37.22M | -56.17M | -53.62M | -64.11M | -83.89M |
Interest Income | n/a | 3.01M | n/a | 4.14M | 1.46M | 939K | 904K | 1.42M | 1.13M | 1.43M | 1.85M | 1.79M | 2.5M | 2.98M | n/a | 2.76M | 2.44M | n/a | 338K | n/a | 1.17M | n/a |
Pretax Income | -4.79M | -6.47M | 73.07M | -2.89M | 73.21M | -14.14M | -8.94M | -10.05M | -15.22M | -10.4M | -5.02M | -7.58M | -14.19M | -21.69M | -14.25M | -15.52M | -22.79M | -39.74M | -57.66M | -55.9M | -52.19M | -79.45M |
Net Income | -5.9M | -4.93M | 61.02M | 3.62M | 54.84M | -13.58M | -15.53M | -12.7M | -16.53M | -11.66M | -8.51M | -8.95M | -15.65M | -22.09M | -10.36M | 916.63M | -8.19M | -25.95M | -32.03M | -35.31M | -52.41M | -79.68M |
Selling & General & Admin | 14.18M | 17.72M | 19.86M | n/a | n/a | n/a | 18.5M | n/a | n/a | n/a | 15.85M | 15.24M | 19.28M | 19.18M | 16.73M | 16.28M | 16.22M | 17.84M | 21.52M | 21.3M | 25.93M | n/a |
Research & Development | 4.71M | 5.83M | 6.96M | 8.11M | 10.49M | 11.45M | 9.38M | 9.27M | 9.95M | 8.97M | 9M | 7.88M | 11.37M | 16.33M | 17.29M | 11.52M | 16.47M | 24.79M | 33.13M | 47.04M | 52.35M | 69.03M |
Other Expenses | 10.12M | n/a | n/a | 10.22M | 7.94M | 6.92M | -9.38M | 9.17M | 10.05M | 7.77M | -9.35M | n/a | -10.2M | -14.75M | -17.29M | -11.02M | -13.46M | -15.47M | -14.76M | -45.27M | -52.35M | -38.48M |
Operating Expenses | 29.01M | 23.55M | 26.82M | 18.33M | 18.43M | 18.37M | 18.5M | 18.44M | 20.01M | 16.74M | 15.49M | 23.11M | 20.45M | 20.76M | 16.73M | 16.79M | 19.23M | 27.17M | 39.89M | 23.07M | 25.93M | 30.55M |
Interest Expense | n/a | n/a | 583K | 573K | 663K | 643K | 643K | 630K | 644K | 629K | 623K | 609K | 568K | 550K | 551K | 1.55M | 2.14M | 2.14M | 11.66M | 2.14M | 11.61M | 12.11M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 4.3M | n/a | n/a | n/a | 5.1M | n/a | n/a | n/a | 8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 29.01M | 23.55M | 28.33M | 26.45M | 28.92M | 29.82M | 27.95M | 27.71M | 29.96M | 25.71M | 23.81M | 24.45M | 29.87M | 35.33M | 32.08M | 26.65M | 34.15M | 50.42M | 71.11M | 66.81M | 77.02M | 98.15M |
Income Tax Expense | 1.11M | -1.54M | 12.04M | -6.5M | 18.37M | -559K | 6.59M | 2.65M | 1.31M | 1.26M | 3.49M | 1.37M | 1.46M | 395K | 3K | 507K | 5K | 524K | 151K | 7K | 220K | 227K |
Shares Outstanding (Basic) | 51.67M | 51.28M | 50.87M | 50.52M | 50.18M | 49.71M | 49.31M | 49.04M | 48.75M | 48.28M | 49.42M | 52.36M | 56.68M | 62.93M | 67.4M | 75.52M | 76.27M | 75.25M | 73.62M | 73.57M | 65.67M | 64.49M |
Shares Outstanding (Diluted) | 51.67M | 51.28M | 53.05M | 51.91M | 50.73M | 49.71M | 49.31M | 49.04M | 48.75M | 48.28M | 49.42M | 52.36M | 56.68M | 62.93M | 67.4M | 75.52M | 76.27M | 75.25M | 73.96M | 73.57M | 65.67M | 64.49M |
EPS (Basic) | -0.11 | -0.10 | 1.20 | 0.07 | 1.09 | -0.27 | -0.31 | -0.26 | -0.34 | -0.24 | -0.17 | -0.17 | -0.28 | -0.35 | -0.21 | 12.14 | -0.11 | -0.34 | -0.44 | -0.48 | -0.80 | -1.24 |
EPS (Diluted) | -0.11 | -0.10 | 1.15 | 0.07 | 1.08 | -0.27 | -0.31 | -0.26 | -0.34 | -0.24 | -0.17 | -0.17 | -0.28 | -0.35 | -0.21 | 12.14 | -0.11 | -0.34 | -0.43 | -0.48 | -0.80 | -1.24 |
EBITDA | -4.79M | -5.64M | 75.16M | -1.91M | 74.28M | -13.08M | -7.6M | -8.85M | -12.33M | -9.34M | -6.21M | -5.64M | -13.72M | -22.58M | -13.38M | -12.9M | -19.16M | -26.92M | -37.54M | -50.24M | -39.17M | -82.34M |
EBIT | -4.79M | -6.47M | 73.65M | -2.32M | 73.87M | -13.5M | -8.3M | -9.28M | -12.75M | -9.77M | -6.6M | -6.97M | -14.95M | -23.34M | -13.7M | -13.69M | -20.1M | -27.9M | -37.8M | -51.84M | -40.57M | -83.89M |
Depreciation & Amortization | n/a | 835K | 1.51M | 409K | 409K | 413K | 695K | 429K | 427K | 432K | 392K | 1.34M | 1.23M | 758.75K | 320K | 797K | 936K | 982K | 252K | 1.6M | 1.41M | 1.55M |
Add to Watchlist
Select watchlists to add or remove TBPH